Sophia Operating Cycle from 2010 to 2026
| SOPH Stock | USD 5.17 0.08 1.52% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 171.96 | Current Value 232.74 | Quarterly Volatility 63.61322675 |
Check Sophia Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sophia Genetics' main balance sheet or income statement drivers, such as Tax Provision of 1.5 M, Net Interest Income of 1.7 M or Interest Income of 4.1 M, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0 or PTB Ratio of 2.29. Sophia financial statements analysis is a perfect complement when working with Sophia Genetics Valuation or Volatility modules.
Sophia | Operating Cycle | Build AI portfolio with Sophia Stock |
The Operating Cycle trend for Sophia Genetics SA offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Sophia Genetics is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Sophia Genetics' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Sophia Genetics SA over the last few years. It is Sophia Genetics' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sophia Genetics' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Sophia Operating Cycle Regression Statistics
| Arithmetic Mean | 265.04 | |
| Geometric Mean | 256.88 | |
| Coefficient Of Variation | 24.00 | |
| Mean Deviation | 58.32 | |
| Median | 314.61 | |
| Standard Deviation | 63.61 | |
| Sample Variance | 4,047 | |
| Range | 165 | |
| R-Value | (0.83) | |
| Mean Square Error | 1,364 | |
| R-Squared | 0.68 | |
| Significance | 0.000042 | |
| Slope | (10.42) | |
| Total Sum of Squares | 64,746 |
Sophia Operating Cycle History
About Sophia Genetics Financial Statements
Investors use fundamental indicators, such as Sophia Genetics' Operating Cycle, to determine how well the company is positioned to perform in the future. Although Sophia Genetics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 171.96 | 232.74 |
Currently Active Assets on Macroaxis
When determining whether Sophia Genetics SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sophia Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sophia Genetics Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sophia Genetics Sa Stock:Check out the analysis of Sophia Genetics Correlation against competitors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is there potential for Health Care Equipment & Supplies market expansion? Will Sophia introduce new products? Factors like these will boost the valuation of Sophia Genetics. If investors know Sophia will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Sophia Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share | Quarterly Revenue Growth 0.228 | Return On Assets | Return On Equity |
The market value of Sophia Genetics SA is measured differently than its book value, which is the value of Sophia that is recorded on the company's balance sheet. Investors also form their own opinion of Sophia Genetics' value that differs from its market value or its book value, called intrinsic value, which is Sophia Genetics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Sophia Genetics' market value can be influenced by many factors that don't directly affect Sophia Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sophia Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sophia Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Sophia Genetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.